Vol. 14 No. 4 (2014)

Published: 2014-11-24

Editorials

We know what to do, so why aren’t we doing it?

Rowan Hillson

128-130
- HTML
- PDF

Reviews

Insulin induced lipodystrophy

Prathima Kadiyala, Shernaz Walton, Thozhukat Sathyapalan

131-133
- HTML
- PDF

Learning from practice

Dipeptidyl peptidase 4 inhibitors in routine clinical practice: experiences from a Scottish teaching hospital

Amy L Brown, Christopher R Sainsbury, Carl Fenelon, Alexander B Mullen, Gregory C Jones

134-137
- HTML
- PDF
Dapagliflozin: Clinical practice compared with pre-registration trial data

Andrew P McGovern, Nina Dutta, Neil Munro, Kenneth Watters, Michael Feher

138-143
- HTML
- PDF

Current Topics

Type 1 diabetes: time to act to raise standards of care

Anne Kilvert, Charles Fox, Robert Gregory, Patrick Sharp

144-147
- HTML
- PDF
Assessing the value of the Ambulatory Glucose Profile in clinical practice

Stephan Matthaei

148-152
- HTML
- PDF
Consensus recommendations for the use of Ambulatory Glucose Profile in clinical practice

Stephan Matthaei, Ramiro Antuña DeAlaiz, Emanuele Bosi, Mark Evans, Nel Geelhoed-Duijvestijn, Michael Joubert

153-157
- HTML
- PDF
JBDS guideline for the use of VRIII in medical patients – a commentary

Jonathan Webber

158-160
- HTML
- PDF

Case Reports

A case of haemochromatosis and diabetes: a missed opportunity

Hiang Leng Tan, Feaz Babwah, Muhammad Imran Butt, Najeeb Waheed

161-163
- HTML
- PDF

Meeting Reports

ABCD Autumn Meeting 6-7 November 2014

Andrew Macklin

164-165
- HTML
- PDF
Reflections on the 50th annual meeting of the EASD

Mike Gwilt

166-167
- HTML
- PDF

ABCD News

ABCD News

Umesh Dashora

168-170
- HTML
- PDF